Twist Bioscience Corporation TWST Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $376.57M+20.3% | $312.97M+27.7% | $245.11M+20.4% | $203.56M+53.8% | ||
| $185.57M+3.3% | $179.63M+15.6% | $155.38M+30.2% | $119.33M+48.0% | ||
| $191M+43.2% | $133.35M+48.6% | $89.73M+6.5% | $84.23M+62.9% | ||
| 50.7%+8.1pp | 42.6%+6.0pp | 36.6%-4.8pp | 41.4%+2.3pp | ||
| $80.29M-11.6% | $90.85M-15.0% | $106.9M-11.1% | $120.31M+74.2% | ||
| $246.98M+13.1% | $218.4M+15.1% | $189.74M-10.9% | $212.95M+56.7% | ||
| $512.83M-3.9% | $533.81M+15.5% | $462.27M+5.5% | $438.34M+53.8% | ||
| -$136.26M+38.3% | -$220.83M-1.7% | -$217.16M+7.5% | -$234.78M-53.7% | ||
| -36.2%+34.4pp | -70.6%+18.0pp | -88.6%+26.7pp | -115.3%+0.1pp | ||
| $11.36M-25.9% | $15.34M+6.8% | $14.37M+369% | $3.06M+604% | ||
| —— | -$2.68M-299% | -$671K+38.3% | -$1.09M+20.7% | ||
| -$76.95M+63.0% | -$208.17M-2.3% | -$203.47M+10.9% | -$228.27M-48.2% | ||
| $720K— | —— | —— | -$10.7M— | ||
| -$77.67M+62.8% | -$208.73M-2.0% | -$204.62M+6.1% | -$217.86M-43.2% | ||
| -20.6%+46.1pp | -66.7%+16.8pp | -83.5%+23.5pp | -107%+7.9pp | ||
| -$1.31+63.6% | -$3.600.0% | -$3.60+10.2% | -$4.01-27.3% | ||
| -$1.30+63.9% | -$3.600.0% | -$3.60+10.2% | -$4.01-27.3% | ||
| 239.8M+3.6% | 231.4M+1.9% | 227.1M+6.4% | 213.6M+11.3% | ||
| 238.6M+3.1% | 231.4M+1.9% | 227.1M+6.4% | 213.6M— | ||
| -$77.76M+62.7% | -$208.49M-1.2% | -$206M+6.3% | -$219.89M-45.0% | ||
| —— | —— | —— | $0— | ||
| —— | $31K+103% | -$1.15M-17.4% | -$983K-308% | ||
| —— | $203K+189% | -$227K+85.8% | -$1.59M-11,286% | ||
| —— | -$2.68M-299% | -$671K+38.3% | -$1.09M+20.7% | ||
| -$136.26M+38.3% | -$220.83M-1.7% | -$217.16M+7.5% | -$234.78M-53.7% | ||
| -$111.41M+41.2% | -$189.4M-0.8% | -$187.85M+13.9% | -$218.26M-52.7% | ||
| -$111.41M+41.2% | -$189.4M-0.8% | -$187.85M+13.9% | -$218.26M-52.7% | ||
| -29.6%+30.9pp | -60.5%+16.1pp | -76.6%+30.6pp | -107.2%+0.8pp | ||
| -$136.26M+38.3% | -$220.83M-1.7% | -$217.16M+7.5% | -$234.78M-53.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Twist Bioscience Corporation's revenue?
- Twist Bioscience Corporation (TWST) generated $409.5M in revenue over the trailing twelve months, up 17.8% year over year.
- Is Twist Bioscience Corporation profitable?
- Twist Bioscience Corporation is not currently profitable: it reported a net loss of $81.3M over the trailing twelve months, a -19.8% net margin.
- What are Twist Bioscience Corporation's profit margins?
- Gross margin is 52.1% and operating margin is -33.9%, with a -19.8% net margin.
- What is Twist Bioscience Corporation's earnings per share?
- Twist Bioscience Corporation's diluted EPS over the trailing twelve months is $-1.33.
- Where does Twist Bioscience Corporation's income statement data come from?
- Every line is extracted from Twist Bioscience Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
